Literature DB >> 21855628

HIV-1 Tat increases oxidant burden in the lungs of transgenic mice.

Adela Cota-Gomez1, Ariana C Flores, Xiao-Feng Ling, Marileila Varella-Garcia, Sonia C Flores.   

Abstract

Chronic human immunodeficiency virus infection is associated with higher incidence of pulmonary complications including hypertension, vasculopathy, lymphocytic alveolitis, and interstitial pneumonitis not attributed to either opportunistic infections or presence of the virus. The Tat (transactivator of transcription) protein, a required transactivator for expression of full-length viral genes, is pleiotropic and influences expression of cellular inflammatory genes. Tat-dependent transactivation of cellular genes requires specific mediators, including NF-κB, widely recognized as sensitive to changes in cellular oxidant burden. We hypothesized that overproduction of Tat leads to increased oxidant burden and to alterations in basal inflammatory status as measured by NF-κB activation. We engineered transgenic mouse lines that express Tat (86-amino-acid isoform) in the lung under the control of the surfactant protein C promoter. Tat-transgenic mice exhibit increased pulmonary cellular infiltration, increased nitrotyrosine and carbonyl protein modifications, and increased levels of NF-κB, MnSOD, and thioredoxin-interacting protein. These data indicate that Tat increases oxidant burden and resets the threshold for inflammation, which may increase susceptibility to secondary injuries. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855628      PMCID: PMC3188365          DOI: 10.1016/j.freeradbiomed.2011.07.023

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  49 in total

1.  Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1.

Authors:  T Martin; P M Cardarelli; G C Parry; K A Felts; R R Cobb
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

2.  Altered cytokine production and accessory cell function after HIV-1 infection.

Authors:  J Yoo; H Chen; T Kraus; D Hirsch; S Polyak; I George; K Sperber
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

3.  Cellular oxygen toxicity. Oxidant injury without apoptosis.

Authors:  J A Kazzaz; J Xu; T A Palaia; L Mantell; A M Fein; S Horowitz
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

4.  Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals.

Authors:  R Buhl
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

Review 5.  Antioxidant status and lipid peroxidation in patients infected with HIV.

Authors:  A Favier; C Sappey; P Leclerc; P Faure; M Micoud
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

6.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

Authors:  M O Westendorp; R Frank; C Ochsenbauer; K Stricker; J Dhein; H Walczak; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

Review 7.  Superoxide radical: controversies, contradictions, and paradoxes.

Authors:  J M McCord
Journal:  Proc Soc Exp Biol Med       Date:  1995-06

8.  Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice.

Authors:  H J Brady; D J Abraham; D J Pennington; C G Miles; S Jenkins; E A Dzierzak
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.

Authors:  M O Westendorp; V A Shatrov; K Schulze-Osthoff; R Frank; M Kraft; M Los; P H Krammer; W Dröge; V Lehmann
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

10.  Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B.

Authors:  C J Wrighton; R Hofer-Warbinek; T Moll; R Eytner; F H Bach; R de Martin
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  16 in total

1.  Repression of Nrf2/ARE regulated antioxidant genes and dysregulation of the cellular redox environment by the HIV Transactivator of Transcription.

Authors:  Ari Simenauer; Betelhem Assefa; Jose Rios-Ochoa; Kara Geraci; Brooks Hybertson; Bifeng Gao; Joe McCord; Hanan Elajaili; Eva Nozik-Grayck; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-06-22       Impact factor: 7.376

2.  Screening for Chronic Obstructive Pulmonary Disease (COPD) in an Urban HIV Clinic: A Pilot Study.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  AIDS Patient Care STDS       Date:  2015-02-27       Impact factor: 5.078

Review 3.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

Review 4.  The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.

Authors:  Sharilyn Almodovar
Journal:  Viral Immunol       Date:  2014-05-05       Impact factor: 2.257

5.  Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques.

Authors:  Sharilyn Almodovar; Jessica Swanson; Luis D Giavedoni; Sreetharan Kanthaswamy; Carlin S Long; Norbert F Voelkel; Michael G Edwards; Joy M Folkvord; Elizabeth Connick; Susan V Westmoreland; Paul A Luciw; Sonia C Flores
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

6.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

Review 7.  Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1.

Authors:  P S S Rao; Narasimha M Midde; Duane D Miller; Subhash Chauhan; Anil Kumar; Santosh Kumar
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

8.  The HIV-Tat protein interacts with Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells.

Authors:  Terrin L Manes; Ari Simenauer; Jason L Geohring; Juliana Flemming; Michael Brehm; Adela Cota-Gomez
Journal:  Free Radic Biol Med       Date:  2019-12-19       Impact factor: 7.376

Review 9.  Maintaining lung health with longstanding HIV.

Authors:  Paul Collini; Alison Morris
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

10.  Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development.

Authors:  Kristi M Porter; Erik R Walp; Shawn C Elms; Robert Raynor; Patrick O Mitchell; David M Guidot; Roy L Sutliff
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.